PRESS RELEASE: Putting Australian Cannabis Patients First

Cannabis importers allegedly held to different standards.

Responding to recent media reports regarding imported cannabis products, Biortica Agrimed CEO, Tom Varga commented, “Let’s all just keep in mind what our priority is here. This is about providing the highest quality medicinal cannabis, affordably, to Australian patients in need.”

“There is an Australian shortage of medicinal cannabis. As Australia’s largest B2B medicinal cannabis grower, our goal is full import replacement and ultimately export as well, but let’s get patients the treatment they need first.”
“What I will say however, is that all medicinal cannabis supplied to patients must meet Australian standards of efficacy and safety.”

“All medicinal cannabis needs to comply with TGO 93 and TGO 100 as a minimum. No ifs, buts or exceptions,” he said. “To patients and practitioners I’d say, look for the ‘Product of Australia’ logo as your guarantee of efficacy and safety.”

Contact:
Tom Varga
CEO, Biortica Agrimed
e [email protected]
m +61 (0)499 991 745

Media Contacts:

Name: John Kochanski, CMOCompany: Biortica Agrimed LtdEmail: Phone: 0411831122

About Biortica Agrimed Ltd

View Website

Biortica Agrimed Ltd Biortica Agrimed Ltd is Australia’s largest fully vertically integrated commercial grower of medicinal plants. Our B2B operations are seamlessly integrated from plant genetics through to supply of medicinal plants in commercial quantities. We employ glasshouse-based horticulture, to both, protect our valuable medicinal crops, and equally to minimise our environmental impact, thereby protecting the planet. Our goal is to significantly improve human health outcomes by supplying high quality agricultural medicinal plants, at scale, to uniform high quality standards year-round.